Pleomorphic leiomyosarcoma

Pleomorphic leiomyosarcoma is defined as a sarcoma showing typical leiomyosarcomatous fascicles but in which more than two thirds of the tumour is of pleomorphic morphology. Pleomorphic leiomyosarcoma differs from ordinary leiomyosarcoma in its morphology, reduced immunoreactivity for muscle markers, increased proliferative activity and more aggressive behavior. Pleomorphic leiomyosarcoma accounts for about 9% of all leiomyosarcomas.

Clinical features

Pleomorphic leiomyosarcoma tends to occur in middle aged to elderly adults, particularly in the extremities and retroperitoneum.

Histopathology

In most (23 of 281) cases, the pleomorphic areas blend with the leiomyosarcomatous fascicular areas.

Immunohistochemistry (with ordinary leiomyosarcomas and MFH for comparison):

 

pleomorphic leiomyosarcoma

ordinary leiomyosarcoma

storiform-pleomorphic MFH

fascicular areas

pleomorphic areas

desmin

18/281

10/281, 3/62

15/201

3/161 focally positive

muscle actin (HHF-35)

26/281

13/281, 2/62

14/201

1/161 focally positive

SMA

24/281

14/281

15/201

1/161 focally positive

calponin

20/281

16/281

18/201

2/161 focally positive

h-caldesmon

11/281

5/281

11/201

0/161 focally positive

Myo-D1

0/51

0/51

 

 

myogenin

0/51

0/51

 

 

p53 staining more than 10% of nuclei

8/281

5/201

5/161

murine double-minute 2

15/281

8/201

6/161

average MIB-1 labelling index

26.11

26.21

12.91

16.61

Cases with prominent osteoclast-like giant cells were excluded from this study1.

Differential diagnosis

Among sarcomas, prominent pleomorphism is seen in pleomorphic sarcoma NOS (storiform-pleomorphic MFH), pleomorphic liposarcoma and pleomorphic rhabdomyosarcoma.

Prognosis

Of 22 with a significant period of follow up, 15 died of disease1.

References

1 Oda, Y., Miyajima, K., Kawaguchi, K.et al. Pleomorphic leiomyosarcoma: clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma. Am J Surg Pathol 2001; 25:1030-1038.

2 Hashimoto, H., Daimaru, Y., Tsuneyoshi, M., Enjoji, M. Soft tissue sarcoma with additional anaplastic components. A clinicopathologic and immunohistochemical study of 27 cases. Cancer 1990;66:1578-1589.

This page last revised 26.12.2001.